AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Headlines
Stepan Company is a leading manufacturer in the specialty chemicals sector, focusing on surfactants and polymers.
The company reported record earnings for the full year 2022, with significant contributions from its surfactant segment.
Recent developments include the upcoming launch of an alkoxylation facility in Pasadena, Texas, aimed at enhancing production capabilities.
Stepan Company's Role in the Specialty Chemicals Sector
Stepan Company, established in 1932 and headquartered in Northbrook, Illinois, operates within the specialty chemicals industry. The company specializes in producing surfactants and polymers, which are integral to various consumer and industrial products. Surfactants enhance the foaming and cleaning capabilities of items like detergents, shampoos, and toothpaste, while polymers are utilized in applications such as thermal insulation and coatings.
Financial Performance and Key Metrics
In 2022, Stepan Company achieved record earnings, driven by robust performance in its surfactant segment. The company's market capitalization stands at approximately $1.37 billion, with a price-to-earnings ratio of 30.39. Liquidity ratios include a quick ratio of 0.86 and a current ratio of 1.27, indicating its ability to meet short-term obligations. The debt-to-equity ratio is 0.29, reflecting a conservative approach to leveraging.
Institutional Investment and Shareholder Composition
Institutional investors hold a significant portion of Stepan's shares. For instance, The Manufacturers Life Insurance Company increased its holdings by 4.8% during the second quarter, now owning 11,920 shares. Creative Planning also expanded its position by 13.9% in the same period, holding 9,346 shares. Overall, institutional investors own approximately 82.70% of the company's stock, indicating strong interest from large-scale investors.
Recent Developments and Strategic Initiatives
Stepan is advancing its new alkoxylation facility in Pasadena, Texas, scheduled to commence operations by mid-2024. This facility aims to enhance the company's production capacity and align with regulatory standards concerning 1,4 dioxane, underscoring Stepan's commitment to sustainability.
Leadership and Corporate Governance
The company is led by President and CEO Scott Behrens. Recent leadership changes include the departure of Tom Giese, Vice President of Commercial Development for Surfactants, in March 2024, and the appointment of Susan Lewis as Director in February 2024. These developments reflect Stepan's ongoing efforts to strengthen its leadership team.
